Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study | |
Li, Jin; Xu, Ruihua; Qin, Shukui; Liu, Tianshu; Pan, Hongming; Xu, Jianming; Bi, Feng; Lim, Robert; Zhang, Suzhan; Ba, Yi | |
刊名 | FUTURE ONCOLOGY |
2018 | |
卷号 | Vol.14 No.20页码:2030-2043 |
关键词 | aflibercept Asia-Pacific FOLFIRI mCRC oxaliplatin-pretreated |
ISSN号 | 1479-6694 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/1833978 |
专题 | 四川大学 |
作者单位 | 1.Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore 2.Sichuan Univ, Dept Med Oncol, West China Hosp, Chengdu, Sichuan, Peoples R China 3.Zhejiang Univ, Affiliated Hosp 2, Canc Inst, Hangzhou, Zhejiang, Peoples R China 4.Tianjin Med Univ Canc Inst & Hosp, Dept Gastrointestinal Oncol, Tianjin, Peoples R China 5.Sanofi, Res & Dev, Vitry Sur Seine, France 6.Sanofi, Res & Dev, Beijing, Peoples R China 7.Zhejiang Univ, Dept Med Oncol, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China 8.Kobe City Med Ctr Gen Hosp, Dept Med Oncol, Kobe, Hyogo, Japan 9.Fujian Prov Canc Hosp, Dept Med Oncol, Fuzhou, Fujian, Peoples R China 10.Mil Hosp China, Peoples Liberat Army PLA Canc Ctr, Nanjing, Jiangsu, Peoples R China |
推荐引用方式 GB/T 7714 | Li, Jin,Xu, Ruihua,Qin, Shukui,et al. Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study[J]. FUTURE ONCOLOGY,2018,Vol.14 No.20:2030-2043. |
APA | Li, Jin.,Xu, Ruihua.,Qin, Shukui.,Liu, Tianshu.,Pan, Hongming.,...&Ba, Yi.(2018).Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study.FUTURE ONCOLOGY,Vol.14 No.20,2030-2043. |
MLA | Li, Jin,et al."Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study".FUTURE ONCOLOGY Vol.14 No.20(2018):2030-2043. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论